X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CTMX

Closed

Cytomx Therapeutics Inc

2.36
+0.09 (+3.96%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.27
Day's Range: 2.15 - 2.38
Send
When Written:
 
1.51
CytomX Therapeutics Inc is a biotechnology company that focuses on developing innovative cancer treatments. The company's proprietary Probody platform enables the creation of highly selective therapies that can target cancer cells while sparing healthy tissues.

CytomX's pipeline includes multiple Probody therapeutics in various stages of development, including treatments for breast cancer, prostate cancer, and solid tumors. The company has partnerships with several pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, and ImmunoGen, to develop and commercialize its Probody therapeutics.

CytomX was founded in 2008 and is headquartered in South San Francisco, California. The company went public in 2015 and is listed on the NASDAQ stock exchange under the ticker symbol "CTMX."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X